The Board of Directors of Suzhou Highfine Biotech Co., Ltd. has authorized a buyback plan on February 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
44.53 CNY | +0.29% | -2.02% | -25.80% |
13/05 | Suzhou Highfine Biotech Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
25/04 | Suzhou Highfine Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.80% | 663M | |
+2.46% | 102B | |
-8.98% | 60.79B | |
+74.76% | 48.86B | |
+13.97% | 37.96B | |
+4.56% | 32.37B | |
+14.72% | 20.64B | |
+11.17% | 16.58B | |
+8.81% | 13.93B | |
-3.19% | 13.25B |
- Stock Market
- Equities
- 301393 Stock
- News Suzhou Highfine Biotech Co., Ltd.
- Suzhou Highfine Biotech Co., Ltd. authorizes a Buyback Plan.